The consolidated financial results for the third quarter of the fiscal year ending March 2023 reflect a period of mixed performance for Daicel Corporation. While the company achieved sales revenue of 404.5 billion yen, representing a 17.9% year-on-year increase, operating income declined by 6.9% to 36.6 billion yen. The growth in top-line revenue was primarily driven by strategic price revisions, cost-reduction initiatives, and favorable foreign exchange impacts. Conversely, the contraction in operating income was attributed to sluggish automobile production, weakened demand for electronic devices, and rising costs for raw materials, fuel, and logistics. The geographic and industry scope of these results spans global markets, with significant exposure to the automotive, semiconductor, and LCD panel sectors. Performance across segments varied, as the company faced headwinds from production adjustments in the LCD market and a slower-than-anticipated recovery in automotive manufacturing, exacerbated by semiconductor shortages and COVID-19-related lockdowns in China. While the Materials and Engineering Plastics segments managed to exceed internal profit plans, the Medical/Healthcare, Smart, and Safety segments fell short of expectations. To address these challenges, the company is implementing a series of corrective measures aimed at improving profitability for the remainder of the fiscal year. These actions include a rigorous review of corporate and production expenses, inventory reduction strategies, and targeted efforts to expand sales in high-demand areas, such as acetate tow and specific cosmetic ingredients. Looking forward, the company plans to provide a comprehensive revision of its mid-term management strategy in May 2023, alongside the full-year financial results, to better align its operational structure with current market realities and demand recovery timelines.